Price
Financials
Standalone, Rs crore| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 51 | 82 | 87 | 99 | 147 | 146 |
| Expenses | 42 | 68 | 74 | 79 | 122 | 117 |
| Operating Profit | 9 | 14 | 13 | 20 | 25 | 29 |
| OPM % | 17% | 17% | 15% | 20% | 17% | 20% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 1 | 2 | 2 | 2 | 4 | 6 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | 7 | 12 | 11 | 18 | 20 | 24 |
| Tax % | 26% | 35% | 29% | 32% | 26% | 41% |
| Net Profit | 5 | 8 | 8 | 12 | 15 | 14 |
| EPS in Rs | 26.60 | 6.70 | 4.97 | 7.46 | 8.58 | 7.95 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 57 | 65 | 82 | 132 | 186 | 293 |
| Expenses | 55 | 61 | 73 | 110 | 153 | 239 |
| Operating Profit | 3 | 4 | 9 | 22 | 33 | 53 |
| OPM % | 4.9% | 7% | 11% | 17% | 18% | 18% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 0 | 1 | 1 | 3 | 3 | 10 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 3 | 7 | 19 | 29 | 44 |
| Tax % | 33% | 29% | 33% | 32% | 31% | 34% |
| Net Profit | 1 | 2 | 5 | 13 | 20 | 29 |
| EPS in Rs | 9.99 | 11.39 | 25.04 | 10.99 | 12.43 | 16.53 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 39% | 53% | 57% | ||
| Compounded Profit Growth | % | 85% | 84% | 46% | ||
| Stock Price CAGR | % | % | % | -36% | ||
| Return on Equity | % | 27% | 26% | 20% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1 | 2 | 2 | 12 | 16 | 18 |
| Reserves | 4 | 6 | 10 | 14 | 92 | 173 |
| Borrowings | 10 | 9 | 18 | 25 | 50 | 94 |
| Other Liabilities | 8 | 17 | 19 | 48 | 40 | 52 |
| Total Liabilities | 23 | 33 | 49 | 99 | 198 | 338 |
| Fixed Assets | 6 | 5 | 7 | 18 | 17 | 28 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 48 |
| Other Assets | 17 | 28 | 42 | 80 | 180 | 261 |
| Total Assets | 23 | 33 | 49 | 99 | 198 | 338 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -3 | 3 | -11 | 13 | -69 | -20 |
| Cash from Investing Activity | 0 | 0 | -2 | -13 | -11 | -76 |
| Cash from Financing Activity | 5 | -2 | 8 | 4 | 83 | 89 |
| Net Cash Flow | 2 | 1 | -4 | 4 | 4 | -7 |
| Free Cash Flow | -3 | 2 | -12 | 0 | -69 | -33 |
| CFO/OP | -106% | 72% | -113% | 67% | -188% | -22% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 63 | 57 | 73 | 128 | 134 |
| Inventory Days | 28 | 63 | 94 | 91 | 104 | 94 |
| Days Payable | 37 | 94 | 84 | 130 | 77 | 56 |
| Cash Conversion Cycle | 36 | 33 | 67 | 35 | 156 | 172 |
| Working Capital Days | -12 | -7 | 27 | 38 | 139 | 108 |
| ROCE % | 26% | 35% | 54% | 31% | 24% |
| Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 71.53% | 71.53% | 71.53% | 65.21% | 65.21% | 64.84% |
| FIIs | 4.13% | 1.83% | 1.46% | 0.59% | 0.15% | 0.18% |
| DIIs | 5.88% | 5.38% | 5.01% | 3.89% | 3.56% | 3.56% |
| Public | 18.46% | 21.26% | 22.00% | 30.31% | 31.09% | 31.42% |
| No. of Shareholders | 1,525 | 1,897 | 2,104 | 1,865 | 2,777 | 3,241 |
Fundamentals
Market Cap₹ 691 Cr.
Current Price₹ 388
Stock P/E23.6
Book Value₹ 108
ROCE24.4 %
ROE19.6 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)57%
Compounded Profit Growth (TTM)46%
Standalone figures.
Valuation
Market capRs 656 Cr
Enterprise valueRs 659 Cr
P/E (TTM)309.35x
Price to book85.95x
Price to sales10.06x
EV / EBITDA141.14x
EV / EBIT160.38x
EV / sales10.11x
Price to cash flow255.18x
Earnings yield0.32%
Profitability
Operating margin (excl. other income)6.69%
Operating margin (incl. other income)7.16%
EBITDA margin7.16%
Pre-tax margin4.58%
Net profit margin3.25%
ROE33.54%
ROCE26.41%
ROA7.61%
ROIC (approx.)26.74%
Tax rate28.76%
Other income / net worth4.06%
Growth
Sales growth (latest year)13.74%
Profit growth (latest year)55.88%
Per share
EPS (TTM)Rs 1.19
EPS (latest year)Rs 11.39
Book value per shareRs 4.29
Sales per shareRs 36.65
Cash flow per shareRs 1.44
Free cash flow per shareRs -18.54
Efficiency
Asset turnover1.97x
Fixed asset turnover12.12x
Inventory turnover5.68x
Inventory days64 days
Debtor days63 days
Debtors turnover5.77x
Creditor days56 days
Cash conversion cycle172 days
Working capital days108 days
Leverage
Total debtRs 9 Cr
Cash and bankRs 5 Cr
Net debtRs 3 Cr
Debt to equity1.13x
Net debt / EBITDA0.71x
Interest coverage3.67x
Owners' fund to total sources23.04%
Debt to assets26.06%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -33 Cr
FCFE (approx.: FCF + change in debt)Rs -34 Cr
Cash from ops / profit, 5 years-1.22x
Sales to cash flow25.38x
Statement figures
Net sales (TTM)Rs 65 Cr
Net sales (latest year)Rs 65 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 5 Cr
PBDT (TTM)Rs 4 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 58 Cr
Total expenditure (latest year)Rs 61 Cr
Total income (latest year)Rs 66 Cr
Share capitalRs 2 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 8 Cr
Total assetsRs 33 Cr
Net blockRs 5 Cr
ReceivablesRs 11 Cr
InventoryRs 10 Cr
Other liabilitiesRs 17 Cr
Shares outstanding (crore)1.78
Ownership
Promoter holding64.84% (-6.69 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | OSELDEVICE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -5.7% | -2.8% | -2.9 pts |
| 1 month | -1.1% | -6.8% | +5.7 pts |
| 3 months | -23.8% | -7.6% | -16.1 pts |
| 6 months | -27.5% | +0.4% | -27.9 pts |
| 1 year | -41.6% | -9.9% | -31.7 pts |
Red flags
F-score 6 of 8| explain | Weak cash conversion Cash from operations was -22% of net profit over the last 2 years |
| explain | Receivables outrunning sales Receivables grew 61% vs sales +14% in 2026 |
| look | Inventory outrunning sales Inventory grew 160% vs sales +14% in 2026 |
| look | Share dilution Share count up 36% in a year |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹146 Cr +78.0% vs Mar 2024.
Net profit ₹14 Cr +75.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
| Vaidya Sane Ayurved Laboratories Ltd | 176 | 19.6 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of OSEL Devices Ltd?
OSEL Devices Ltd (OSELDEVICE) has a market capitalisation of Rs 691 Cr. at the 2026-10-01 close.
What is the P/E ratio of OSEL Devices Ltd?
OSEL Devices Ltd trades at a P/E of 23.6 on trailing twelve-month profit, at the 2026-10-01 close.
What were OSEL Devices Ltd's latest quarterly results?
In the Mar 2026 quarter, OSEL Devices Ltd sales was Rs 146 Cr (+78.0% vs Mar 2024) and net profit was Rs 14 Cr.
What is the 52-week high and low of OSEL Devices Ltd?
The 52-week high is Rs 835.00 and the 52-week low is Rs 349.75.